Phase II study of hypofractionated proton beam therapy for localized prostate cancer
Phase 2
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000017679
- Lead Sponsor
- Proton Medical Research Center, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 125
Inclusion Criteria
Not provided
Exclusion Criteria
Severe complications such as heart failure, and liver dysfunction other active malignant tumors history of pelvis irradiation not to allow discontinuing anticoagulant and antiplatelet therapy severe cognitive impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year grade 2 late toxicity rate
- Secondary Outcome Measures
Name Time Method Acute reaction, late tpxicity, 5 year survival, 5 year progression free survival